Biomerieux S.A. · Class II · Cleared Aug 22, 2019
| K-number | K191953 |
| Device name | ETEST Imipenem/Relebactam (IPR) (0.002/4-32/4 ug/mL) |
| Applicant | Biomerieux S.A. |
| Product code | JWY |
| Device class | Class II |
| Decision date | Aug 22, 2019 |
| Decision | Substantially Equivalent |
| Regulation | 866.1640 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov